Akero Therapeutics Inc. (AKRO)’s Financial Results Comparing With Jaguar Health Inc. (NASDAQ:JAGX)

Both Akero Therapeutics Inc. (NASDAQ:AKRO) and Jaguar Health Inc. (NASDAQ:JAGX) are each other’s competitor in the Biotechnology industry. Thus the contrast of their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Akero Therapeutics Inc. 20 0.00 8.81M -3.22 0.00
Jaguar Health Inc. 1 0.00 9.22M -161.25 0.00

Demonstrates Akero Therapeutics Inc. and Jaguar Health Inc. earnings per share (EPS), gross revenue and valuation.

Profitability

Table 2 shows us the return on equity, return on assets and net margins of both businesses.

Net Margins Return on Equity Return on Assets
Akero Therapeutics Inc. 43,059,628.54% 0% 0%
Jaguar Health Inc. 1,286,990,508.10% -380.6% -79.9%

Liquidity

Akero Therapeutics Inc.’s Current Ratio and Quick Ratio are 29.4 and 29.4 respectively. The Current Ratio and Quick Ratio of its competitor Jaguar Health Inc. are 0.3 and 0.2 respectively. Akero Therapeutics Inc. therefore has a better chance of paying off short and long-term obligations compared to Jaguar Health Inc.

Analyst Ratings

Akero Therapeutics Inc. and Jaguar Health Inc. Recommendations and Ratings are available in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Akero Therapeutics Inc. 0 0 0 0.00
Jaguar Health Inc. 0 0 2 3.00

Competitively Jaguar Health Inc. has a consensus target price of $4, with potential upside of 555.09%.

Insider and Institutional Ownership

Roughly 48.5% of Akero Therapeutics Inc. shares are owned by institutional investors while 1.1% of Jaguar Health Inc. are owned by institutional investors. Insiders owned 17.8% of Akero Therapeutics Inc. shares. Comparatively, Jaguar Health Inc. has 13.23% of it’s share owned by insiders.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Akero Therapeutics Inc. 5.86% 27.17% 0% 0% 0% 32.1%
Jaguar Health Inc. -2.27% -64.46% -88.75% -90.4% -97.61% -89.26%

For the past year Akero Therapeutics Inc. had bullish trend while Jaguar Health Inc. had bearish trend.

Summary

Akero Therapeutics Inc. beats on 6 of the 10 factors Jaguar Health Inc.

Napo Pharmaceuticals, Inc., a human health company, focuses on developing and commercializing novel gastrointestinal prescription products from plants. Its products include Mytesi, an FDA approved product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Napo Pharmaceuticals, Inc. was formerly known as PS Pharmaceuticals, Inc. The company was founded in 2001 and is based in San Francisco, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.